Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.

Langen RC, Gosker HR, Remels AH, Schols AM.

Int J Biochem Cell Biol. 2013 Oct;45(10):2245-56. doi: 10.1016/j.biocel.2013.06.015. Epub 2013 Jul 1. Review.

PMID:
23827718
2.

Glucocorticoid-induced skeletal muscle atrophy.

Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP.

Int J Biochem Cell Biol. 2013 Oct;45(10):2163-72. doi: 10.1016/j.biocel.2013.05.036. Epub 2013 Jun 24. Review.

PMID:
23806868
3.

Muscle wasting in cancer.

Johns N, Stephens NA, Fearon KC.

Int J Biochem Cell Biol. 2013 Oct;45(10):2215-29. doi: 10.1016/j.biocel.2013.05.032. Epub 2013 Jun 11. Review.

PMID:
23770121
4.

Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.

Joassard OR, Amirouche A, Gallot YS, Desgeorges MM, Castells J, Durieux AC, Berthon P, Freyssenet DG.

Int J Biochem Cell Biol. 2013 Nov;45(11):2444-55. doi: 10.1016/j.biocel.2013.07.019. Epub 2013 Aug 2.

PMID:
23916784
5.

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

Plant PJ, Brooks D, Faughnan M, Bayley T, Bain J, Singer L, Correa J, Pearce D, Binnie M, Batt J.

Am J Respir Cell Mol Biol. 2010 Apr;42(4):461-71. doi: 10.1165/rcmb.2008-0382OC. Epub 2009 Jun 11.

PMID:
19520920
6.

Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.

Yoshida T, Tabony AM, Galvez S, Mitch WE, Higashi Y, Sukhanov S, Delafontaine P.

Int J Biochem Cell Biol. 2013 Oct;45(10):2322-32. doi: 10.1016/j.biocel.2013.05.035. Epub 2013 Jun 13. Review.

7.

Electrostimulation during hindlimb unloading modulates PI3K-AKT downstream targets without preventing soleus atrophy and restores slow phenotype through ERK.

Dupont E, Cieniewski-Bernard C, Bastide B, Stevens L.

Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R408-17. doi: 10.1152/ajpregu.00793.2009. Epub 2010 Nov 24.

8.

Regulation of muscle protein synthesis and the effects of catabolic states.

Gordon BS, Kelleher AR, Kimball SR.

Int J Biochem Cell Biol. 2013 Oct;45(10):2147-57. doi: 10.1016/j.biocel.2013.05.039. Epub 2013 Jun 12. Review.

9.

NF-κB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy.

Haegens A, Schols AM, Gorissen SH, van Essen AL, Snepvangers F, Gray DA, Shoelson SE, Langen RC.

Am J Physiol Lung Cell Mol Physiol. 2012 Jan 1;302(1):L103-10. doi: 10.1152/ajplung.00084.2011. Epub 2011 Oct 14.

10.

Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.

Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A.

Cell Signal. 2013 Oct;25(10):1939-48. doi: 10.1016/j.cellsig.2013.06.007. Epub 2013 Jun 11. Review.

PMID:
23770291
11.

Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.

Chatterton DE, Nguyen DN, Bering SB, Sangild PT.

Int J Biochem Cell Biol. 2013 Aug;45(8):1730-47. doi: 10.1016/j.biocel.2013.04.028. Epub 2013 May 6. Review.

PMID:
23660296
12.

Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.

Doucet M, Russell AP, Léger B, Debigaré R, Joanisse DR, Caron MA, LeBlanc P, Maltais F.

Am J Respir Crit Care Med. 2007 Aug 1;176(3):261-9. Epub 2007 May 3.

PMID:
17478621
13.

Downregulation of Akt/mammalian target of rapamycin pathway in skeletal muscle is associated with increased REDD1 expression in response to chronic hypoxia.

Favier FB, Costes F, Defour A, Bonnefoy R, Lefai E, Baugé S, Peinnequin A, Benoit H, Freyssenet D.

Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1659-66. doi: 10.1152/ajpregu.00550.2009. Epub 2010 Mar 17.

14.

Factors contributing to muscle wasting and dysfunction in COPD patients.

Wüst RC, Degens H.

Int J Chron Obstruct Pulmon Dis. 2007;2(3):289-300. Review.

15.

Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy.

Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA, Kandarian SC.

FASEB J. 2002 Apr;16(6):529-38.

PMID:
11919155
16.

Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease.

Jagoe RT, Engelen MP.

Eur Respir J Suppl. 2003 Nov;46:52s-63s. Review.

17.

Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.

Ju CR, Chen RC.

Respir Med. 2012 Jan;106(1):102-8. doi: 10.1016/j.rmed.2011.07.016. Epub 2011 Aug 15.

18.
19.

Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.

Op den Kamp CM, Langen RC, Minnaard R, Kelders MC, Snepvangers FJ, Hesselink MK, Dingemans AC, Schols AM.

Lung Cancer. 2012 Apr;76(1):112-7. doi: 10.1016/j.lungcan.2011.09.012. Epub 2011 Oct 20.

20.

Muscle wasting from kidney failure-a model for catabolic conditions.

Wang XH, Mitch WE.

Int J Biochem Cell Biol. 2013 Oct;45(10):2230-8. doi: 10.1016/j.biocel.2013.06.027. Epub 2013 Jul 16. Review.

Supplemental Content

Support Center